Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-068207
Filing Date
2011-07-26
Accepted
2011-07-26 12:59:09
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a59571e10vq.htm 10-Q 523371
2 EX-31.1 a59571exv31w1.htm EX-31.1 5776
3 EX-31.2 a59571exv31w2.htm EX-31.2 6078
4 EX-32.1 a59571exv32w1.htm EX-32.1 3361
5 EX-32.2 a59571exv32w2.htm EX-32.2 3116
  Complete submission text file 0000950123-11-068207.txt   5058423

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT wpi-20110630.xml EX-101.INS 741143
7 EX-101 SCHEMA DOCUMENT wpi-20110630.xsd EX-101.SCH 43955
8 EX-101 CALCULATION LINKBASE DOCUMENT wpi-20110630_cal.xml EX-101.CAL 85158
9 EX-101 LABELS LINKBASE DOCUMENT wpi-20110630_lab.xml EX-101.LAB 395499
10 EX-101 PRESENTATION LINKBASE DOCUMENT wpi-20110630_pre.xml EX-101.PRE 265452
11 EX-101 DEFINITION LINKBASE DOCUMENT wpi-20110630_def.xml EX-101.DEF 132170
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13305 | Film No.: 11986793
SIC: 2834 Pharmaceutical Preparations